Scarica l'app Stockscreener
66.43
1.71%
1.12
Dopo l'orario di chiusura:
66.43
Precedente Chiudi:
$65.31
Aprire:
$65.15
Volume 24 ore:
646.87K
Relative Volume:
1.56
Capitalizzazione di mercato:
$3.27B
Reddito:
$1.11B
Utile/perdita netta:
$205.95M
Rapporto P/E:
16.16
EPS:
4.11
Flusso di cassa netto:
$254.64M
1 W Prestazione:
-11.62%
1M Prestazione:
-13.16%
6M Prestazione:
-22.47%
1 anno Prestazione:
-1.26%
Intervallo 1D:
$65.15
$66.57
Intervallo di 1 settimana:
$62.95
$72.89
Portata 52W:
$62.95
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Nome
Prestige Consumer Healthcare Inc
Settore
Telefono
(914) 524-6800
Indirizzo
660 WHITE PLAINS RD., TARRYTOWN, NY
Confronta PBH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
66.43 | 3.14B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Downgrade | Sidoti | Buy → Neutral |
| 2024-06-21 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2022-11-17 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-06-29 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-04-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-04-07 | Ripresa | Sidoti | Neutral |
| 2020-03-26 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-24 | Iniziato | Oppenheimer | Perform |
| 2020-03-19 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2019-01-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2017-05-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Reiterato | B. Riley & Co. | Buy |
| 2016-11-17 | Iniziato | Gabelli & Co | Buy |
| 2016-08-12 | Aggiornamento | Sidoti | Neutral → Buy |
| 2016-03-08 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Iniziato | Piper Jaffray | Overweight |
| 2015-11-30 | Downgrade | Jefferies | Hold → Underperform |
| 2014-04-28 | Reiterato | B. Riley & Co. | Buy |
| 2014-04-28 | Reiterato | Oppenheimer | Outperform |
| 2013-07-09 | Iniziato | B. Riley & Co. | Buy |
Mostra tutto
Prestige Consumer Healthcare Inc Borsa (PBH) Ultime notizie
Prestige Consumer Healthcare (PBH) Trims Outlook as Sales Dip—Is the Acquisition Strategy Still on Track? - simplywall.st
Prestige Consumer Healthcare's Strategic Acquisition and Q1 Earnings: A Value Investment Case in a Resilient OTC Sector - AInvest
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its First-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
Prestige Consumer Healthcare Acquires Pillar5 Pharma for Expansion - MSN
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q1 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’ - insights.citeline.com
Prestige Consumer Healthcare's Q1 2026: Key Contradictions in Clear Eyes Supply, Market Share, and Margin Outlook - AInvest
Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare stock hits 52-week low at 64.83 USD - Investing.com Nigeria
Prestige Brands stock price target lowered to $100 at Canaccord on eye care supply issues - Investing.com Nigeria
Prestige Consumer Healthcare's Strategic Path to Recovery: Can Shareholders Capitalize on a Turnaround in Eye Care and Margin Expansion? - AInvest
Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot - Manistee News Advocate
Prestige Consumer Healthcare: Strategic Acquisitions and Innovation Drive Long-Term Value Creation - AInvest
Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery - MSN
Prestige Consumer Healthcare Q1 Earnings and Strategic Acquisition of Pillar5 Pharma - AInvest
Prestige Consumer Healthcare’s Q1 Earnings and Strategic Moves - TipRanks
Prestige Consumer Healthcare Q1 2026 Earnings Call Transcript - MarketBeat
Prestige Consumer Healthcare shares fall 10.14% intraday after missing Q1 revenue estimates and lowering fiscal 2026 outlook. - AInvest
Prestige Consumer Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Prestige Consumer Healthcare Inc. Q1 Profit Decreases, Misses Estimates - Nasdaq
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Prestige Consumer Healthcare's Strategic Acquisition of Anjac SAS: A Catalyst for OTC Men's Health Dominance - AInvest
Prestige Consumer Healthcare Eyes Growth Despite Revenue Shortfall - Finimize
Prestige Consumer Healthcare on Aug 4, unit entered agreement with Anjac SASSEC filing - MarketScreener
Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve - Investing.com Nigeria
Prestige Consumer Healthcare Q1 FY26 slides: Revenue drops on supply issues, margins improve By Investing.com - Investing.com South Africa
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance
Prestige Consumer Healthcare Q1 Revenue Falls 6.6% Amid Supply Constraints and Order Timing Shifts - AInvest
Prestige Consumer Healthcare's Strategic Acquisition of Pillar5 Pharma: A Masterstroke in Supply Chain Resilience and Competitive Edge - AInvest
Prestige Consumer Healthcare Reports Lower Q1 Earnings Than ExpectedNews and Statistics - IndexBox
Prestige (PBH) Q1 Revenue Falls 6.6% - The Globe and Mail
Prestige Consumer's Strategic Turnaround: Assessing Brand Resilience and M&A-Driven Growth in a High-Margin Sector - AInvest
Prestige Consumer Healthcare Inc. SEC 10-Q Report - TradingView
Prestige Consumer misses Q1 revenue estimates, to acquire Pillar5 Pharma - MarketScreener
Prestige Consumer Healthcare's Fiscal 2026 Q1 Earnings: A Strategic Masterclass in Brand Diversification and Operational Excellence - AInvest
Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results - GlobeNewswire
Prestige Healthcare Reports Mixed Q1 Results, Makes Strategic Eye Care Supplier Acquisition - Stock Titan
Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
Does Prestige Consumer Healthcare Inc. fit your quant trading modelPredictive AI Engine for Smart Investing - Newser
Using Python tools to backtest Prestige Consumer Healthcare Inc. strategiesImmediate Entry Point Prediction Strategy - Newser
Prestige Consumer Healthcare Inc. Flashes Rebound Signal in Oversold ConditionStrong Buy With Technical Confidence Supported - beatles.ru
Insights Ahead: Prestige Consumer's Quarterly Earnings - 富途牛牛
TheraTears® Unveils "It's a Science" Marketing Campaign - Yahoo Finance
Applying sector rotation models to Prestige Consumer Healthcare Inc.Chart-Based Entry Confirmation for Beginners - Newser
Why Prestige Consumer Healthcare Inc. stock attracts strong analyst attentionHigh Yield Signals with Entry Timing - Newser
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Price Is Out Of Tune With Earnings - simplywall.st
Applying Wyckoff theory to Prestige Consumer Healthcare Inc. stockWeekly High Conviction Trade Setup Analysis - Newser
Resistance Break Could Fuel Prestige Consumer Healthcare Inc. RallyOptimized Watchlist With Daily Adjustments Launched - metal.it
Prestige Consumer Healthcare Inc Azioni (PBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):